Novo Nordisk follows Eli Lilly on insulin price cuts
Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.
Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.
Sanofi acquires Provention Bio, and its TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D).
Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.
As the number of satellites skyrockets, scientists have called for a legally-binding global treaty to ensure the safety of Earth's orbit from space
The WHO has advocated a ‘social math’ technique to magnify the issue of road safety globally for non-governmental organisations.
Merck announced its experimental trial on patients with pulmonary arterial hypertension had led to an extension in walking distance and reduced exacerbating the
Alembic Pharmaceuticals got the USFDA note for a generic cancer treatment drug
Vattenfall study shows how seabirds avoid wind turbine wings, which can be useful for compliance approvals for offshore wind farms